<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02981004</url>
  </required_header>
  <id_info>
    <org_study_id>CS-09-015-GE-TV</org_study_id>
    <nct_id>NCT02981004</nct_id>
  </id_info>
  <brief_title>PAR I - Patient-to-Annulus Relation I</brief_title>
  <acronym>PARI</acronym>
  <official_title>PAR I - Prothesis-to-Annulus Relation (PAR) as Predictor of Hemodynamic Outcome in Aortic Valve Replacement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Jude Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Prosthesis-to-Annulus Relation I (PAR I) trial is a German multicenter study assessing
      the relation between the prosthetic GOA and the area of LVOT as potentially new parameter for
      the prediction of hemodynamic outcome. The results may possibly guide future valve size
      selection an may allow prediction of functionally relevant PPM (Patient-Prosthesis-Mismatch)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Great debates revolve around the hemodynamic performance of prosthetic tissue valves. It is
      influenced by the design and the specific sizing strategy. Design determines the actual
      geometric orifice area (GOA), sizing strategy the actual size of the selected valve.
      Currently, hemodynamic performance is generally assessed by determining the effective orifice
      area (EOA, derived from the continuity equation by relating flow velocities and LVOT area).
      The question whether a prosthesis patient mismatch (PPM) is present is then addressed by
      relating EOA to body surface area (EOAi). However, this relation may not be reasonable
      because EOAi relates flow velocity twice to patient-specific anatomic parameters (LVOT area
      and body surface area) . Considering this potential methodological flaw, debate and confusion
      regarding PPM is easily understood, despite the fact that, intuitively leaving a gradient
      behind after aortic valve replacement cannot be irrelevant. Thus a reliable and comparable
      method to determine the presence of PPM is needed. In PAR I Trial the relation between true
      prothetic GOA and LVOT area will be assesses as a potentially new parameter for prediction of
      hemodynamic outcome, to possibly guide future valve size selection (inclusive valve-in-valve)
      and to allow the detection of functionally relevant PPM. In the trial it will be assessed how
      anatomic dimensions of patients and implanted valves relate to each other and whether they
      allow the prediction of hemodynamic outcome.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">April 2017</completion_date>
  <primary_completion_date type="Anticipated">April 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>recording of hemodynamic outcome of a aortic valve in mutual dependence of anatomical facts on the basis of echocardiographic parameter</measure>
    <time_frame>postprocedure before discharge (less than 30 days after implant)</time_frame>
    <description>Echocardiographic evaluation of the anatomical facts e.g. Left ventricular outflow area</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality 30 days after implant</measure>
    <time_frame>30 days</time_frame>
    <description>Mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Morbidity 30 days after implant</measure>
    <time_frame>30 days</time_frame>
    <description>Morbidity</description>
  </secondary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Aortic Valve Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with aortic valve disease selected for tissue valve implantation (routine care)
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:1.Patient has an indication for primary, isolated aortic valve
        implantation 2. Patient is above 18 Years old 3. Patient has signed patient informed
        consent 4. foreseen implantation of an Epic, Epic supra or Trifecta valve 5. Patient has
        sinus rhythm

        Exclusion Criteria:

          1. Patient is younger than 18 years

          2. Patient has active endocarditis

          3. Patient is not able or does not want to participate on follow-up

          4. Patient is pregnant or nursing

          5. Surgical widening of outflow tract is planned

          6. Left ventricular ejection fraction is smaller than 50%

          7. Patient has a mitral valve or tricuspid valve insufficiency or stenosis bigger or
             equal Grade II
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Torsten Doenst, M.D.Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Head of Cardiac surgery department</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Torsten Doenst, M.D. Ph.D.</last_name>
    <phone>004936419322901</phone>
    <email>doenst@med.uni-jena.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Herzzentrum Dresden</name>
      <address>
        <city>Dresden</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Klaus Matschke, M.D.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Asklepios St. Georg</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Oberhoffer</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Cardiothoracic Surgery</name>
      <address>
        <city>Jena</city>
        <zip>07747</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Torsten Doenst, M.D. Ph.D.</last_name>
      <phone>004936419322901</phone>
      <email>doenst@med.uni-jena.de</email>
    </contact>
    <investigator>
      <last_name>Mahmoud Diab, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Bogenhausen</name>
      <address>
        <city>Munich</city>
        <zip>81925</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Walter Eichinger, M.D.</last_name>
      <phone>0049 8992702631</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Herz- und Kreislaufzentrum Rotenburg / Fulda</name>
      <address>
        <city>Rotenburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ardawan Rastan, M.D.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Krankenhaus der Barmherzigen Br√ºder</name>
      <address>
        <city>Trier</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexandros Paraforos, M.D.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital of Ulm</name>
      <address>
        <city>Ulm</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hagen Gorki, M.D.</last_name>
    </contact>
    <contact_backup>
      <last_name>Robert Bauernschmitt, M.D.</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 21, 2016</study_first_submitted>
  <study_first_submitted_qc>November 30, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 2, 2016</study_first_posted>
  <last_update_submitted>November 30, 2016</last_update_submitted>
  <last_update_submitted_qc>November 30, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Aortic valve disease, patient prosthesis mismatch</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Defects, Congenital</mesh_term>
    <mesh_term>Heart Valve Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

